Comparison between Eris Lifesciences IPO and PSP Projects IPO.
Eris Lifesciences IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while PSP Projects IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Eris Lifesciences IPO is up to ₹1,740.49 Cr whereas the issue size of the PSP Projects IPO is up to ₹211.68 Cr. The final issue price of Eris Lifesciences IPO is ₹603.00 per share and of PSP Projects IPO is ₹210.00 per share.
| Eris Lifesciences IPO | PSP Projects IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹10 per share |
| Issue Price (Lower) | ₹600.00 per share | ₹205.00 per share |
| Issue Price (Upper) | ₹603.00 per share | ₹210.00 per share |
| Issue Price (Final) | ₹603.00 per share | ₹210.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹60.00 per share | |
| Market Lot Size | 24 shares | 70 shares |
| Fresh Issue Size | 0 shares | 72,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹151.20 Cr |
| OFS Issue Size | 2,88,75,000 shares | 28,80,000 shares |
| OFS Issue Size (Amount) | up to ₹1,740.49 Cr | up to ₹60.48 Cr |
| Issue Size Total | 2,88,75,000 shares | 1,00,80,000 shares |
| Issue Size Total (Amount) | up to ₹1,740.49 Cr | up to ₹211.68 Cr |
Eris Lifesciences IPO opens on Jun 16, 2017, while PSP Projects IPO opens on May 17, 2017. The closing date of Eris Lifesciences IPO and PSP Projects IPO is Jun 20, 2017, and May 19, 2017, respectively.
| Eris Lifesciences IPO | PSP Projects IPO | |
|---|---|---|
| Anchor Bid Date | Jun 15, 2017 | May 16, 2017 |
| Issue Open | Jun 16, 2017 | May 17, 2017 |
| Issue Close | Jun 20, 2017 | May 19, 2017 |
| Basis Of Allotment (Tentative) | Jun 23, 2017 | May 24, 2017 |
| Initiation of Refunds (Tentative) | Jun 27, 2017 | May 26, 2017 |
| Credit of Share (Tentative) | Jun 28, 2017 | May 26, 2017 |
| Listing date (Tentative) | Jun 29, 2017 | May 29, 2017 |
| Anchor Lockin End date 1 | Jul 23, 2017 | Jun 23, 2017 |
| Anchor Lockin End date 2 | Sep 21, 2017 | Aug 22, 2017 |
Eris Lifesciences IPO P/E ratio is , as compared to PSP Projects IPO P/E ratio of .
| Eris Lifesciences IPO | PSP Projects IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | ||||||
| Promoter Shareholding (Post-Issue) | ||||||
| P/E Ratio | ||||||
| Market Cap | ₹8291.25 Cr. | ₹756.00 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Eris Lifesciences IPO Retail Individual Investors (RII) are offered 28,72,500 shares while in PSP Projects IPO retail investors are offered 28,72,500 shares. Qualified Institutional Buyers (QIB) are offered 86,17,500 shares in Eris Lifesciences IPO and 30,24,000 shares in PSP Projects IPO.
| Eris Lifesciences IPO | PSP Projects IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,29,26,250 shares | 45,36,000 shares |
| Market Maker Reservation | ||
| QIB | 86,17,500 shares | 30,24,000 shares |
| NII | 43,08,750 shares | 15,12,000 shares |
| RII | 28,72,500 shares | 10,08,000 shares |
| Employee | 1,50,000 shares | |
| Others | ||
| Total | 2,88,75,000 shares | 1,00,80,000 shares |
Eris Lifesciences IPO subscribed 3.29x in total, whereas PSP Projects IPO subscribed 8.58x.
| Eris Lifesciences IPO | PSP Projects IPO | |
|---|---|---|
| QIB (times) | 4.68x | 8.38x |
| NII (times) | 0.45x | 10.39x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.51x | 6.47x |
| Employee (times) | 0.86x | |
| Other (times) | ||
| Total (times) | 3.29x | 8.58x |
